Cylert is the brand name for Pemoline, a stimulant first synthesized in 1913 and used to treat ADHD (attention deficit hyperactivity disorder) and narcolepsy. Pemoline has been pulled from the U.S. market because of reports connecting its use in children to increased risk of liver failure. After the U.S. Food and Drug Administration (FDA) issued a warning not to prescribe Pemoline for ADHD, the manufacturer and patent owner (Abbott Laboratories) stopped making Cylert.
Pemoline was first approved by the FDA in 1975. Since that date, more than 20 liver failures have been linked to the drug. Pemoline is believed to cause hepatoxicity, a chemically induced form of liver damage.
If you or someone you love has used any type of Cylert and experienced detrimental side effects, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.
Defective Drugs & Medical Devices Topics
Latest Articles
Happy New Year 2020
Wishing you happy holidays and a wonderful new year. Best wishes from everyone at GetLegal.
Lee Mas 23 Dec 2019, MondaySlip-and-fall Claims on Commercial Property
Your Best Chance of Recovery When You Are Hurt on Business Premises As a general rule, all property…
Lee Mas 02 Dec 2019, MondayThanksgiving—A Time of Gratitude
Life is about connection… about the power of relationships to help us find and nurture our best se…
Lee Mas 27 Nov 2019, Wednesday